These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30468095)

  • 1. Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications.
    Muniz Júnior RL; Godói IP; Reis EA; Garcia MM; Guerra-Júnior AA; Godman B; Ruas CM
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):473-482. PubMed ID: 30468095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
    Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Aletta A; Jamil KF; Rajamoorthy Y; Hadisoemarto PF; Wagner AL; Groneberg DA; Kuch U; Sasmono RT; Müller R; Imrie A
    Vaccine; 2019 Mar; 37(11):1398-1406. PubMed ID: 30739794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumer willingness to pay for a hypothetical chikungunya vaccine in Brazil and the implications.
    Sarmento TTR; Godói IP; Reis EA; Godman B; Ruas CM
    Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):513-520. PubMed ID: 31815561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications.
    Dias-Godói IP; Tadeu Rocha Sarmento T; Afonso Reis E; Peres Gargano L; Godman B; de Assis Acurcio F; Alvares-Teodoro J; Guerra Júnior AA; Mariano Ruas C
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):119-129. PubMed ID: 33993823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine Demand and Willingness-to-pay for Arbovirus Vaccines: A Cross-sectional Survey in Rural Guatemala.
    Olson D; Rick AM; Krager S; Lamb M; Asturias EJ
    Pediatr Infect Dis J; 2018 Nov; 37(11):1184-1189. PubMed ID: 30153226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications.
    Labis da Costa MJ; Nascimento GC; Athie TS; Sales Silva J; Reis EA; Martin AP; Godman B; Dias Godói IP
    J Comp Eff Res; 2022 Mar; 11(4):263-274. PubMed ID: 35029122
    [No Abstract]   [Full Text] [Related]  

  • 7. Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study.
    Harapan H; Mudatsir M; Yufika A; Nawawi Y; Wahyuniati N; Anwar S; Yusri F; Haryanti N; Wijayanti NP; Rizal R; Fitriani D; Maulida NF; Syahriza M; Ikram I; Fandoko TP; Syahadah M; Asrizal FW; Jamil KF; Rajamoorthy Y; Wagner AL; Groneberg DA; Kuch U; Müller R; Sasmono RT; Imrie A
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30453663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications.
    Athie TS; Nascimento GC; Labis da Costa MJ; Sales Silva J; Reis EA; Martin AP; Godman B; Dias Godói IP
    J Comp Eff Res; 2021 Jun; 10(8):659-672. PubMed ID: 33851872
    [No Abstract]   [Full Text] [Related]  

  • 9. Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia
    Godói IP; Santos AS; Reis EA; Lemos LL; Brandão CM; Alvares J; Acurcio FA; Godman B; Guerra Júnior AA
    Front Pharmacol; 2017; 8():41. PubMed ID: 28210223
    [No Abstract]   [Full Text] [Related]  

  • 10. Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study.
    Nogueira VG; Reis EA; Godman B; Martin AP; Godói IPD
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jul; ():. PubMed ID: 39049463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach.
    Al-Hanawi MK; Vaidya K; Alsharqi O; Onwujekwe O
    Appl Health Econ Health Policy; 2018 Apr; 16(2):259-271. PubMed ID: 29307076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia.
    Harapan H; Wagner AL; Yufika A; Setiawan AM; Anwar S; Wahyuni S; Asrizal FW; Sufri MR; Putra RP; Wijayanti NP; Salwiyadi S; Maulana R; Khusna A; Nusrina I; Shidiq M; Fitriani D; Muharrir M; Husna CA; Yusri F; Maulana R; Rajamoorthy Y; Groneberg DA; Müller R; Mudatsir M
    Vaccine; 2020 Oct; 38(43):6800-6806. PubMed ID: 32861468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
    Chen YT; Ying YH; Chang K; Hsieh YH
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dengue, zika, chikungunya and the development of vaccines].
    Kantor IN
    Medicina (B Aires); 2018; 78(1):23-28. PubMed ID: 29360072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
    Aumann I; Treskova M; Hagemann N; von der Schulenburg JM
    Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study.
    Yeo HY; Shafie AA
    Cost Eff Resour Alloc; 2018; 16():60. PubMed ID: 30479577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method.
    Tambor M; Pavlova M; Rechel B; Golinowska S; Sowada C; Groot W
    Soc Sci Med; 2014 Sep; 116():193-201. PubMed ID: 25016327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
    Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
    PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnant women's attitudes toward Zika virus vaccine trial participation.
    Goldfarb IT; Jaffe E; James K; Lyerly AD
    Vaccine; 2018 Oct; 36(45):6711-6717. PubMed ID: 30268731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia.
    Shoukat A; Vilches T; Moghadas SM
    BMC Med; 2018 Jul; 16(1):100. PubMed ID: 29966516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.